Breaking News
March 19, 2018 - AcelRx Announces Receipt of Type A FDA Meeting Minutes and Plans to Resubmit the DSUVIA New Drug Application in Q2 2018
March 19, 2018 - Eye Docs Adopt EHRs Despite Reservations
March 19, 2018 - CRISPR enhances cancer immunotherapy
March 19, 2018 - Study finds first evidence of delayed aging among Americans
March 19, 2018 - Essential oils linked to abnormal breast development in boys
March 19, 2018 - ‘Tummy Tuck’ Relieved Postpartum Back Pain/Incontinence
March 19, 2018 - New biomarkers for neuroblastoma, a type of cancer in children
March 19, 2018 - Hookah Smoking Carries a Poisoning Risk
March 19, 2018 - Do Mood and Anxiety Affect MS Disability?
March 19, 2018 - Mean depth of ultrasonographic penetration greater in autism
March 19, 2018 - Platypus milk may help combat antibiotic resistance
March 19, 2018 - U.S. IDE study of THERMOCOOL SMARTTOUCH SF Catheter completes patient enrollment
March 18, 2018 - E-cigarette use exposes adolescents to potentially cancer-causing chemicals
March 18, 2018 - GOP Senator: Solve Opioid Crisis Through Community, Not Policy
March 18, 2018 - Why is ADHD more common in boys than girls?
March 18, 2018 - Measles alert after two passengers with the disease fly into US
March 18, 2018 - FDA looks to remove nicotine from cigarettes
March 18, 2018 - FDA moves to cut nicotine in cigarettes, helping smokers kick habit
March 18, 2018 - Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis
March 18, 2018 - Surgery Tied to Better Outcomes in Kids with T2D
March 18, 2018 - Scientists use nanotechnology to detect molecular biomarker for osteoarthritis
March 18, 2018 - Research establishes use of chimeric cells as potential therapy for Duchenne muscular dystrophy
March 18, 2018 - Researcher working to develop improved endoscopic probe for colonoscopies
March 18, 2018 - Researchers develop way to sequence entire fetal genome by modifying prenatal testing method
March 18, 2018 - FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application
March 18, 2018 - P2Y12 Tx Subsidy Yields Positive Response from Docs, Patients
March 18, 2018 - Are Proteins in Formula Linked to Type 1 Diabetes?
March 18, 2018 - Exercise does not seem to increase bone marrow edema in healthy people
March 18, 2018 - Researchers delineate architecture of nuclear pore complex in yeast cells
March 18, 2018 - ‘It’s Just Ghetto-izing People’: What We Heard This Week
March 18, 2018 - Alzheimer’s disease: Neuronal loss very limited
March 18, 2018 - Study reveals impact of intense, changing work schedules experienced by medical interns
March 18, 2018 - Jobs That Keep the Mind Sharp … Even Into Retirement
March 18, 2018 - Facial Scarring Improved with Botulinum Toxin
March 18, 2018 - Data detectives shift suspicions in Alzheimer’s to inside villain
March 18, 2018 - Shorter Preventive TB Tx Effective for HIV+ Patients
March 18, 2018 - New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips
March 18, 2018 - Researchers uncover four microRNAs as potential biomarkers for atrial fibrillation
March 18, 2018 - IRX Therapeutics Announces Initiation of Phase 2 Clinical Trial of IRX-2 in Squamous Cervical or Vulvar Intraepithelial Neoplasia 3
March 18, 2018 - OncoBreak: Learning from Silence; ‘Rigged’ Drug System; NCCN Guidelines Questioned
March 18, 2018 - The coffee cannabis connection
March 18, 2018 - Novel centrifugal-flow pump for heart failure patients provides improved long-term outcomes
March 18, 2018 - U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
March 18, 2018 - Cath Lab Recap: iFR vs FFR $$; Ridaforolimus-Eluting Stent
March 18, 2018 - Tree care workers need better training to handle dangers on the job, study finds
March 18, 2018 - Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds
March 18, 2018 - Transplanting enhanced interneurons restores brain rhythms in mouse model of Alzheimer’s
March 18, 2018 - Gene Therapy Flops for Critical Limb Ischemia
March 17, 2018 - Study spotlights risks in anesthesiologist handoffs
March 17, 2018 - Verb fluency test may be useful tool for differential diagnosis of cognitive failure
March 17, 2018 - Health Tip: Suggestions to Improve Your Cholesterol
March 17, 2018 - Fructans Suspect in Non-Celiac Gluten Sensitivity
March 17, 2018 - Aspirin therapy appears safe before thyroid surgery
March 17, 2018 - Minimally invasive surgical device may one day provide lasting heart repair
March 17, 2018 - UIH and RaySearch enter into new partnership
March 17, 2018 - Is BMI Too Inexact? | Medpage Today
March 17, 2018 - Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms
March 17, 2018 - Leicester research could help identify people with asthma of different severities
March 17, 2018 - Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter
March 17, 2018 - Participants in rogue herpes vaccine research take legal action
March 17, 2018 - Imara Doses First Patient in Phase 2a Clinical Trial of IMR-687 for Sickle Cell Disease
March 17, 2018 - AAP: Prevent Medication Errors by Improving Processes
March 17, 2018 - Severe sleep apnea during REM sleep tied to acute CV events
March 17, 2018 - Alzheimer’s disease also affects small blood vessels
March 17, 2018 - Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 17, 2018 - Switching Biologics in Psoriasis Care
March 17, 2018 - Polygenic risk score may identify alzheimer’s risk in younger populations
March 17, 2018 - Genetic heart mutations account for fewer sudden and unexplained infant deaths
March 17, 2018 - Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration
March 17, 2018 - Researchers team up to improve life for children with microcephaly
March 17, 2018 - Health guide for young women regarding labiaplasty
March 17, 2018 - Inhaled Nitrite Flops as HFpEF Therapy
March 17, 2018 - California mental health tax providing services to needy in L.A. County, study finds
March 17, 2018 - Cancer survivors become fatigued more quickly than their peers, study finds
March 17, 2018 - Study finds common presence of nightmares among U.S. military personnel
March 17, 2018 - Yellow fever outbreak in Brazil necessitates vaccination for travelers
March 17, 2018 - Health Tip: Waist Size May Help Predict Heart Attack
March 17, 2018 - Low-Dose Combo Pill Successfully Takes Down High BP
March 17, 2018 - Most children with sickle cell anemia not receiving key medication to stay healthy
March 17, 2018 - YCC launches new Yale Center for Immuno-Oncology
Aggressive cancer stem cells can now be isolated successfully in a scientific breakthrough

Aggressive cancer stem cells can now be isolated successfully in a scientific breakthrough

image_pdfDownload PDFimage_print

University of Texas at Dallas researchers have managed to formulate a new technique by which they can isolate aggressive cells which can be the main cause behind metastasized cancers or cancers that have spread to other major organs from their primary site of occurrence.

This breakthrough may lead to isolation of these cells that could mean new ways of treatment could be devised against these cells. Results of the study are published in the latest issue of the journal Chemistry – A European Journal.

UT Dallas researchers used 40,000 tiny plastic beads (blue), each coated with a unique chemical compound, to identify one compound that bound only to breast cancer stem cells (red).

UT Dallas researchers used 40,000 tiny plastic beads (blue), each coated with a unique chemical compound, to identify one compound that bound only to breast cancer stem cells (red).

Dr. Jiyong Lee, assistant professor in the Department of Chemistry and Biochemistry in the School of Natural Sciences and Mathematics at UT Dallas explained that this new approach could help find ways in which cancer recurrence could be prevented. Dr Lee explained that not all cancers are same and some grow more aggressively than others. These cancer cells that grow more aggressively than others are the cancer stem cells. They migrate to other sites from the main area of occurrence and give rise to secondary tumors after the first one has been suitably treated.

From left: Kha Andy Minh Tran BS’16; Dr. Luxi Chen, postdoctoral research associate; Chao Long, a doctoral student in chemistry and biochemistry; and Dr. Jiyong Lee, assistant professor of chemistry and biochemistry, were involved in the cancer stem cell study.

From left: Kha Andy Minh Tran BS’16; Dr. Luxi Chen, postdoctoral research associate; Chao Long, a doctoral student in chemistry and biochemistry; and Dr. Jiyong Lee, assistant professor of chemistry and biochemistry, were involved in the cancer stem cell study.

Stem cells and cancer recurrence and spread are innately connected. Stem cells are mother cells that can turn into any cells of the body when programmed. In addition stem cells have the power to renew themselves to live longer than regular cells. They can turn into any cells including muscles, bone marrow cells, skin, major organ cells etc. Cancer stem cells are found in some aggressive tumours that help them grow rapidly and also spread to distant organs. Once the primary tumors are treated and cured, these aggressive stem cells that have migrated to other major organs such as the liver, lungs, bones etc., continue to migrate and set up shop at different parts of the body so to speak. Treatments that can cure the cancer cells at the primary sites are usually fruitless against these cancer stem cells which can travel via blood stream to different organs as cause metastasis or spread of the tumors. These take years to appear after the initial cancer but are more difficult to treat say researchers.

For this breakthrough, Lee and his team of researchers scanned through 40,000 chemical compounds to find which one would successfully bind to the breast cancer stem cells. Once bound the chemical would isolate the cells from their surrounding normal breast cells and breast cancer cells that were not aggressive in nature. They could finally isolate five different compounds or ligands that could bind to the cancer stem cells. They isolated one of these ligands for further evaluation. Lee explained that similar methods could be used to separate the cancer cells from normal cells as well but this study is unique because it could isolate the cancer stem cells from other cancer cells. This approach is a “novel” one he said.

According to Lee, if these cancer stem cells could be isolated and killed, the risk of spread of the cancer would be reduced. He says that this would stop the cancer from renewing itself and also prevent the onset of new cancers. At present there are no drugs that can specifically kill these cancer stem cells he said. One of the reasons for this could be the fact that these cells have never been isolated before.

They incubated a mixture of breast cancer cells and breast cancer stem cells and 40,000 tiny plastic beads that were coated with the new found ligand that could bind to the cancer stem cells. They noted that the ligand could bind specifically to the cancer stem cells and separate them. Now these cancer stem cells thus isolated and the cancer cells left behind were each injected to lab mice. They noted that the lab mice that were given cancer stem cells showed more rapid cancer growth and bigger and aggressive tumors compared to those injected with the cancer cells that were not stem cells. In the latter group there was no tumor growth at all. This means that if these cancer stem cells could be gotten rid of, they could eliminate the risk of tumor spread said Lee. This could pave the way for therapy as well as effective diagnosis of cancers and aggressive cancer spreads.


Tagged with:

About author

Related Articles